Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997943 · ClinicalTrials.gov registry record · NA
SMART Weight Loss Management
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT02997943: Completed NA study, sponsored by Northwestern University.
NCT02997943 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02997943, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The overall objective of this study is to use an innovative experimental approach, the SMART (Sequential Multiple Assignment Randomized Trial), to determine the best way to sequence the delivery of mHealth tools and traditional treatment components in a stepped program of obesity treatments. The SMART approach is a highly efficient strategy for identifying and constructing efficacious adaptive interventions: it accommodates sequential decision-making based on the participant's response to early weight loss treatment components. The proposed treatment package begins with the least expensive components, and for participants identified as treatment non-responders, provides sequential step-up of additional treatment components. By sequentially delivering treatment components based on participant response, SMART permits achievement of the target outcome, weight loss, with least resource consumption and participant burden.
Primary Outcome
Weight measured in the lab, taken without shoes, wearing light clothing on a calibrated beam balance scale
Interventions
- BEHAVIORAL Step 1 Treatment: APP
- BEHAVIORAL Step 1 Treatment: APP + Coaching
- BEHAVIORAL Step 2 Treatment Strategy: Modest Step-up
- BEHAVIORAL Step 2 Treatment Strategy: Vigorous Step-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2021-03-18 |
| Phase | NA |
What the finished NCT02997943 record still lists
NCT02997943 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 4 interventions - of which Step 1 Treatment: APP is the first listed.
NCT02997943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02997943 about?
NCT02997943 is a clinical study titled "SMART Weight Loss Management". The overall objective of this study is to use an innovative experimental approach, the SMART (Sequential Multiple Assignment Randomized Trial), to determine the best way to sequence the delivery of mHealth tools and traditional treatment components in a stepped program of obesity treatments. The SMA...
What is the current status of trial NCT02997943?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2017-06-19. Estimated completion is 2021-03-18.
What interventions are being tested in trial NCT02997943?
The interventions under investigation include: Step 1 Treatment: APP (BEHAVIORAL), Step 1 Treatment: APP + Coaching (BEHAVIORAL), Step 2 Treatment Strategy: Modest Step-up (BEHAVIORAL), Step 2 Treatment Strategy: Vigorous Step-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT02997943?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02997943's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI